借入資本 変化する 日付
Agenus USD 153.98M 15.68M 2026-03
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Amgen USD 51.61B 250M 2026-09
Arrowhead Research USD 824.07M 401.34M 2026-06
AstraZeneca USD 28.8B 2.79B 2026-09
Bristol-Myers Squibb USD 41.85B 244M 2026-09
Gilead Sciences USD 23.82B 17M 2026-09
GlaxoSmithKline GBP 21.7B 7.75B 2026-09
Heron Therapeutics USD 140.64M 975K 2025-12
Incyte USD 28.42M 994K 2026-06
Intrexon USD 0 198.67M 2024-06
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
Ligand Pharmaceuticals USD 1.13B 679.7M 2026-06
MacroGenics USD 163.16M 94.44M 2026-06
MannKind USD 541.7M 3.43M 2026-09
Merck USD 49.69B 1.39B 2026-09
Novartis USD 38.38B 893M 2026-09
Rigel Pharmaceuticals USD 0 0 2024-09
Roche Holding CHF 25.22B 2.21B 2026-06
Sangamo BioSciences USD 0 0 2022-06
Thermo Fisher Scientific USD 39.11B 73M 2026-09
Veracyte USD 0 0 2025-03
Xencor USD 71.93M 5.61M 2026-09